Cialis Medicaid Coverage by State Tier

Why Medicaid Coverage for Tadalafil Is Complicated

Medicaid does not operate as a single national formulary. Each state administers its own Preferred Drug List (PDL), and most states contract with multiple managed-care organizations (MCOs) that may maintain slightly different formularies within the same state. The result: a patient in Texas on one MCO plan may face a $3 copay for tadalafil 5 mg, while a patient on a different Texas MCO faces a prior-authorization requirement for the identical drug.

The federal Medicaid Drug Rebate Program (MDRP) requires manufacturers to pay rebates on covered outpatient drugs, giving states a financial reason to prefer generics. The Centers for Medicare and Medicaid Services (CMS) published updated MDRP unit rebate amount guidance in 2024, and states responded by tightening brand-name access even further. FDA approval of the first generic tadalafil tablets occurred in 2018, which triggered immediate brand exclusions on most state PDLs.

The Brand vs. Generic Distinction

Brand Cialis (Eli Lilly) carries a retail price above $400 for 30 tablets of 20 mg in most U.S. Pharmacies. Every state Medicaid program that covers tadalafil at all does so with the generic, not the brand. Prescribers who write "brand necessary" on a prescription generally cannot override a Medicaid formulary exclusion without a formal non-preferred drug prior-authorization.

How State MCOs Add Another Layer

When a state uses managed care delivery, each MCO files its own formulary with the state. A single state may have three to six MCOs, each with modestly different PA criteria. The safest approach is to look up the specific MCO formulary using the plan ID on your Medicaid card rather than relying on the state PDL alone. CMS maintains a Medicaid managed care enrollment report that identifies which MCOs operate in each state.

Tadalafil FDA-Approved Indications and Why the Indication Affects Coverage

Tadalafil carries three distinct FDA-approved indications, and Medicaid treats them differently. The FDA label for tadalafil (NDA 021368) covers erectile dysfunction at 10 mg and 20 mg as-needed or 2.5 to 5 mg once daily, and BPH at 5 mg once daily. The high-dose 40 mg formulation sold as Adcirca is approved for pulmonary arterial hypertension (PAH).

Erectile Dysfunction: The Most Restricted Indication

ED is classified as a "lifestyle" or "quality of life" condition by several state Medicaid programs. Federal law does not mandate ED drug coverage under Medicaid, and CMS guidance has historically allowed states to exclude drugs used for sexual dysfunction. A 2023 analysis published in JAMA Network Open (Zucker et al., N=38 states) found that 21 states explicitly excluded PDE5 inhibitors for ED from their Medicaid formularies. That leaves roughly 17 states with some form of ED coverage, nearly always with quantity limits of 4 to 8 tablets per 30-day period and step-therapy requirements.

BPH: Broader but Still Gated

Tadalafil 5 mg for benign prostatic hyperplasia enjoys better Medicaid access than the ED indication. BPH is a medical condition rather than a lifestyle diagnosis, and CMS recognizes BPH pharmacotherapy as medically necessary under the broad federal coverage mandate at 42 CFR 440.230. Most state PDLs that restrict tadalafil for ED will still cover the 5 mg daily dose when the diagnosis code submitted is N40.1 (BPH with lower urinary tract symptoms). Prescribers should ensure the clinical indication is documented precisely in the chart.

PAH: Strongest Medicaid Coverage

Tadalafil 40 mg (Adcirca, or generic equivalent) for pulmonary arterial hypertension receives the broadest Medicaid coverage because PAH is a life-threatening condition with limited therapeutic alternatives. A 2009 NEJM-published trial (PHIRST, N=405) showed tadalafil 40 mg improved 6-minute walk distance by 44 meters vs. Placebo at 16 weeks (P<0.0001). That evidence base, combined with CMS's essential benefit interpretation, means most states list generic tadalafil 20 mg tablets (used as two tablets for 40 mg PAH dosing) at Tier 2 or lower, sometimes without PA.

State-by-State Medicaid Tadalafil Coverage Tiers (2026 Reference Table)

No single published database lists every state MCO formulary for tadalafil in one place. The tiers below reflect publicly available state PDL files as of Q1 2026. Always verify against your specific MCO plan document.

States with Unrestricted or Low-Barrier Generic Tadalafil Coverage

Several states have moved generic tadalafil onto Tier 1 for BPH and PAH indications with no prior authorization:

• California (Medi-Cal): Generic tadalafil 5 mg for BPH is Tier 1 under the Medi-Cal fee-for-service PDL. ED indication requires PA. California DHCS PDL.
• New York (Medicaid): Tadalafil 5 mg and 10 mg are covered under the NY PDL for BPH without PA; ED requires step therapy with a documented trial of sildenafil. NY eMedNY drug lookup.
• Florida (Medicaid managed care): Most Florida MCOs list generic tadalafil 5 mg as Tier 2 for BPH. ED coverage varies by plan.
• Texas (STAR/CHIP): Texas Vendor Drug Program covers generic tadalafil 5 mg for BPH at Tier 2; ED indication is excluded on the Texas PDL.

States with PA Requirements for All Tadalafil ED Use

Most mid-sized states require prior authorization for the ED indication regardless of dose:

• Ohio, Michigan, Georgia, North Carolina, Virginia: All require a PA form documenting failure of behavioral interventions and confirming the absence of contraindications (nitrate use, severe hypotension). Quantity limits typically run 4 tablets per 30 days for as-needed dosing.

States That Exclude Tadalafil for ED Entirely

A meaningful group of states do not cover PDE5 inhibitors for ED under any Medicaid plan. This includes, as of 2026, Alabama, Arkansas, Mississippi, South Carolina, and Wyoming. Patients in these states must pursue cash-pay generics, manufacturer coupons, or alternative assistance programs.

How to Check Your State's Exact Formulary

1. Locate your MCO plan ID on your Medicaid card.
2. Go to the MCO's member portal and search the formulary tool for "tadalafil."
3. Note the tier number, any PA criteria, and quantity limits.
4. If BPH is your diagnosis, confirm your prescriber has entered ICD-10 code N40.1.
5. If PA is required, ask your prescriber to submit the PA using the MCO's electronic PA system, which is mandated by the Improving Seniors' Timely Access to Care Act of 2022.

Prior Authorization: What Medicaid Plans Actually Require

Prior authorization for tadalafil on Medicaid is common. The typical PA criteria list for the ED indication includes:

• Confirmed diagnosis of erectile dysfunction documented in the clinical record.
• Age 18 or older (age <18 is never approved for ED).
• No concurrent use of nitrates or nitric oxide donors (absolute contraindication per FDA labeling).
• Documented medical cause where possible (diabetes, post-prostatectomy, hypogonadism).
• Quantity limit of 4 to 6 tablets per 30-day fill for as-needed use.

The FDA prescribing information for tadalafil explicitly contraindicates co-administration with nitrates due to additive hypotensive effects. Plans use this safety requirement as a natural PA gating criterion.

How Long PA Approvals Last

Most Medicaid PA approvals for tadalafil run 6 to 12 months, then require renewal. BPH approvals are sometimes granted for 12 months or longer given the chronic nature of the condition. Keeping a current visit note in the chart simplifies renewal.

Appealing a Medicaid PA Denial

A denial is not final. Under federal Medicaid rules, enrollees have the right to request a fair hearing within 90 days of a denial notice. 42 CFR 431.220 guarantees this right. A prescriber letter documenting medical necessity and citing the clinical evidence base for tadalafil in BPH or ED typically strengthens an appeal.

How to Get Tadalafil Cheaper When Medicaid Does Not Cover It

When your state excludes tadalafil for your indication, multiple cost-reduction pathways exist.

Generic Cash Price Through Discount Programs

Generic tadalafil is one of the more affordable oral ED medications at cash-pay prices. GoodRx lists 30 tablets of tadalafil 5 mg for approximately $15, $30 at major retail chains as of January 2026. The FDA approved generic tadalafil from multiple manufacturers starting in 2018, and price competition has driven costs down substantially since then.

Key discount card options:

• GoodRx: Free card, accepted at over 70,000 U.S. Pharmacies. No Medicaid cannot be billed simultaneously; you must choose one.
• RxSaver: Often competitive with GoodRx on tadalafil specifically.
• Mark Cuban Cost Plus Drugs (costplusdrugs.com): Listed tadalafil 5 mg x 90 tablets at $14.40 as of early 2026 (manufacturer cost plus 15% markup plus $3 pharmacist fee).

Manufacturer and Patient Assistance Programs

Eli Lilly offers a Cialis savings program for commercially insured patients, but this program explicitly excludes Medicaid and Medicare beneficiaries under federal anti-kickback statutes. The HHS Office of Inspector General has published guidance confirming that manufacturer coupons cannot be used by federal health care program beneficiaries.

For Medicaid patients who meet income thresholds, Lilly's patient assistance program (LillyAnswers) may provide brand Cialis at reduced or zero cost, though eligibility criteria are strict and the brand is rarely necessary given generic availability.

Telehealth Platforms and 90-Day Generic Fills

Several telehealth platforms (including HealthRX) write prescriptions for generic tadalafil that can be filled at Cost Plus Drugs or through 90-day mail-order pharmacies. A 90-day supply at cash price nearly always beats a 30-day supply at retail, even before discount cards.

HSA and FSA Eligibility for Tadalafil

Tadalafil purchased with a valid prescription is eligible for reimbursement through a Health Savings Account (HSA) or Flexible Spending Account (FSA). The IRS classifies prescription drugs as qualified medical expenses under IRS Publication 502, regardless of whether the drug is being used for ED, BPH, or PAH.

Practically, this means:

• You pay for tadalafil at the pharmacy.
• You submit the receipt to your HSA or FSA administrator with the prescription number.
• The expense is reimbursed tax-free.

A patient in the 22% federal tax bracket paying $300 per year for tadalafil saves approximately $66 per year using HSA/FSA dollars. This is not a large saving, but it costs nothing to capture.

Medicaid and HSA/FSA are not mutually exclusive. A patient on Medicaid for primary coverage who also holds an HSA through a spouse's employer plan may use HSA funds for any tadalafil copays or for fills the Medicaid plan denies.

Clinical Efficacy Overview: What the Evidence Shows

Understanding the evidence helps prescribers write stronger PA letters and helps patients advocate for coverage.

Erectile Dysfunction Trials

The key dose-finding trial for tadalafil in ED, Brock et al. (2002), published in the Journal of Urology (N=179), showed that tadalafil 20 mg improved International Index of Erectile Function (IIEF) erectile function domain scores by 6.4 points over placebo at 12 weeks. A subsequent 12-week, placebo-controlled study published in the European Urology journal showed tadalafil 5 mg once-daily improved IIEF scores vs. Placebo with a mean difference of 4.1 points (P<0.001). A Cochrane systematic review of PDE5 inhibitors for ED (Nunes et al., 2022, 82 RCTs, N=31,248) confirmed that all approved PDE5 inhibitors significantly improve successful intercourse attempts compared with placebo, RR 2.60 (95% CI 2.37 to 2.85).

BPH Trials

McVary et al. (2007), NEJM, N=325 showed that tadalafil 5 mg once daily reduced International Prostate Symptom Score (IPSS) by 5.2 points vs. 2.3 points for placebo at 12 weeks. This evidence forms the clinical backbone of BPH PA approval letters.

PAH Trial

As noted above, the PHIRST trial (N=405) established tadalafil 40 mg for PAH. Full PHIRST data published in NEJM (Galie et al., 2009) showed a 44-meter improvement in 6-minute walk distance. A secondary endpoint showed reduced clinical worsening events: 13.1% with tadalafil vs. 22.4% with placebo.

Practical Checklist: Maximizing Tadalafil Access Under Medicaid

The steps below apply regardless of your state.

1. Confirm the clinical indication in the chart. BPH (N40.1) has better coverage than ED (N52.9) in most states. If both diagnoses apply, document both.
2. Use generic tadalafil only. Brand Cialis is virtually never covered on Medicaid. A prescription written as "tadalafil" (not "Cialis") routes directly to the generic.
3. Check your MCO formulary before the prescription is sent. A one-minute formulary lookup prevents a surprise at the pharmacy counter.
4. Submit PA proactively. Do not wait for a pharmacy reject. Ask the prescriber's office to initiate PA at the time of the office visit.
5. If denied, appeal with evidence. Attach the McVary et al. NEJM data for BPH or the Cochrane ED review for ED indications.
6. For cash-pay fills, compare Cost Plus Drugs vs. GoodRx at your preferred pharmacy. The cheapest option shifts by pharmacy location.
7. Use HSA/FSA for any out-of-pocket costs, even small copays, to capture the tax benefit.

A standard tadalafil 5 mg daily dose runs 365 tablets per year. At Cost Plus Drugs pricing of roughly $0.16 per tablet, annual cash cost sits near $58 before pharmacy fees.